References
- Liu-DumlaoTKantarjianHThomasDAO’BrienSRavandiFPhiladelphia-positive acute lymphoblastic leukemia: current treatment optionsCurr Oncol Rep201214538739422669492
- WetzlerMDodgeRKMrózekKProspective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experienceBlood199993113983399310339508
- RowleyJDLetter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa stainingNature197324354052902934126434
- OttmannOGPfeiferHFirst-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adultsCurr Opin Oncol200921Suppl 1S43S4619561414
- FieldingAKHow I treat Philadelphia chromosome-positive acute lymphoblastic leukemiaBlood2010116183409341720656928
- JabbourEJCortesJEKantarjianHMResistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment optionsClin Lymphoma Myeloma Leuk201313551552923890944
- BrentjensRJDavilaMLRiviereICD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemiaSci Transl Med20135177177ra138
- BrudnoJNSomervilleRPShiVAllogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host diseaseJ Clin Oncol201634101112112126811520
- ZhuYMWuZTanYPAnti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia: Two case reportsMedicine20169551e567628002337
- ChenYChengYSuoPDonor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantationBr J Haematol2017179459860529076142
- BékássyANHermansJGorinNCGratwohlAGranulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow TransplantationBone Marrow Transplant19961758018088733701
- PoonLMHamdiASalibaROutcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantationBiol Blood Marrow Transplant20131971059106423644077
- OliffARamuNPPoplackDLeukemic relapse 5½ years after allogeneic bone marrow transplantationBlood1978522281284352442
- LawsonSEDarbyshirePJUse of donor lymphocytes in extramedullary relapse of childhood acute lymphoblastic leukaemia following bone marrow transplantationBone Marrow Transplant19982288298309827986
- de La CámaraRFigueraASteegmannJLAllogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia. Results from a single institutionBone Marrow Transplant1992964334381628127
- CormierMGArminARDaneshgariFCastelliMUnusual extramedullary relapse of acute lymphoblastic leukemia in a bone marrow transplant patientJ Surg Oncol19873642902943320576
- RobillardDTKutnyMAChewningJHArbuckleJLExtramedullary relapse of acute lymphoblastic leukemia presenting as abnormal uterine bleeding: a case reportJ Pediatr Adolesc Gynecol201730343143428062243
- TsuruchiNOkamuraJChildhood acute lymphoblastic leukemia relapse in the uterine cervixJ Pediatr Hematol Oncol19961833113138689350
- DaiHZhangWLiXTolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaOncoimmunology2015411e102746926451310
- WengJLaiPQinLA novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemiaJ Hematol Oncol20181112529458388
- ParkJHRivièreIGonenMLong-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemiaN Engl J Med2018378544945929385376
- LiSZhangJWangMTreatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BBBr J Haematol2018181336037129637550
- ZhangYZhangWDaiHAn analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cellsSci China Life Sci201659437938527009300